AI Article Synopsis
- Cancer stem cells (CSCs) play a crucial role in tumor formation and maintenance, showing resistance to standard therapies and contributing to cancer relapse and metastasis.
- Thyroid hormone (TH) has a significant influence on tumorigenesis, affecting the balance of proliferation and differentiation in CSCs, suggesting its potential as an anti-cancer target.
- The review discusses the interactions between TH and colorectal CSCs, highlighting the possibility of targeting TH in treatment strategies to enhance cancer therapies.
Article Abstract
Tumor formation and maintenance depend on a small fraction of cancer stem cells (CSCs) that can self-renew and generate a wide variety of differentiated cells. CSCs are resistant to chemotherapy and radiation, and can represent a reservoir of cancer cells that often cause relapse after treatment. Evidence suggests that CSCs also give rise to metastases. Thyroid hormone (TH) controls a variety of biological processes including the development and functioning of most adult tissues. Recent years has seen the emergence of an intimate link between TH and multiple steps of tumorigenesis. Thyroid hormone controls the balance between the proliferation and differentiation of CSCs, and may thus be a druggable anti-cancer agent. Here, we review current understanding of the effects of TH on colorectal CSCs, including the cross regulatory loops between TH and regulators of CSC stemness. Targeting TH in the tumor microenvironment may improve treatment strategies.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.mce.2017.03.017 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!